Prasinezumab is a new medicine in clinical trials that targets alpha-synuclein, with the aim of slowing Parkinson’s progression. While key trials did not meet their primary goals, encouraging signals keep scientific interest alive.

Learn what Parkinson’s disease really is, which symptoms are most common, how it affects daily life, and what to expect after diagnosis. A simple, practical guide for anyone seeking clear and reliable information.